Global Summit and Award Ceremonies

For Cancer Research & Entrepreneurship

Saturday, October 22, 2022

Co-Hosted by

AIM-HI logo
Global Summit Collage

Thank you for your interest in our Global Summit. Though this year’s event has concluded, all sessions will be availble for viewing in our Oncology Metaverse. Click below to join our virtual community.

Summit Overview

Saturday, Oct. 22

Part I
New Frontiers for Cancer Research
8:45 am -12:25 pm

8:45 – 8:55 am

Welcome and Opening Remarks

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

Session I: Molecular Approaches to Understand and Treat Cancer


8:55 – 10:30 am

Moderator: Web Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor of Medicine, University of California, San Diego and Director of Strategic Alliances, Ludwig Institute for Cancer Research

Panel Members:

  • Ken C. Anderson, M.D., Dana-Farber Cancer Institute, Professor of Medicine, Harvard; Physician Oncology, Brigham and Women’s Hospital
  • J. Silvio Gutkind Ph.D., Professor and Chair, Pharmacology, University of California, San Diego
  • Aaron N. Hata, M.D., Ph.D., Assistant Professor of Medicine, Harvard 
  • Isidore Rigoutsos, Ph.D., Professor in Computational Medicine, Thomas Jefferson University
  • Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University
  • Katherine Uyhazi, M.D., Ph.D., Assistant Professor of Ophthalmology, University of Pennsylvania 

10:30 -10:45 am: Coffee Break

Session II: New Approaches to Treat Breast, Pancreatic, and Head & Neck Cancer

10:45 am – 12:20 pm

Moderator: Jennifer Grandis, M.D., American Cancer Society Professor of Otolaryngology, University of California, San Francisco

Panel Members: 

  • Lisa Coussens, Ph.D., Professor and Chair, Department of Cell, Developmental & Cancer Biology, Oregon Health and Sciences University
  • Daniel A. Haber, M.D., Ph.D., Director, Massachusetts General Hospital Cancer Center
  • Courtney Houchen, M.D., Professor, Chief of Digestive Diseases and Nutrition, Oklahoma  University School of Medicine
  • Daniel E. Johnson, Ph.D., Professor and Vice Chair of Research, Otolaryngology and Head and Neck Surgery, University of California, San Francisco
  • Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard 
  • Xiang-Lei Yang, Ph.D., Professor of Molecular Biology and Medicine, Scripps Research

12:20 – 12:25 pm

Closing Remarks: 

Alfred Slanetz, Ph.D. Chairman of Board of Directors, NFCR; CEO of Geneius Biotechnology

Part II
Luncheon Award Ceremony for
Entrepreneurship & Women’s Leadership
12:30-2:00 pm

Emcee: Rose Wang, MBA, Executive Advisor of AIM-HI Accelerator Fund

Introduction of the AIM-HI Leadership & Entrepreneurship program

Sujuan Ba, Ph.D., CEO & Co-Founder of AIM-HI Accelerator Fund

Award Presentation of the AIM-HI Beacon Award for Women Leaders in Oncology

  • Overview of the Beacon Award Selection Process: Web Cavenee, Ph.D., Co-Chair of the Selection Committee of the Beacon Award
  • Introduction of the Awardee: Janet Woodcock, M.D., Principal Deputy Commissioner of the U.S. Food and Drug Administration
  • Presenting the Beacon Award Medallion to the Recipient by the Award Selection Committee Members

2022 Beacon Award Winner Award Speech: Anna Barker, Ph.D., Chief Strategy Officer of Ellison Institute for Transformative Medicine

Award Presentation of the Top Finalists for the 2022 Women’s Venture Competition & 2022 BRACE Award Venture Competition: Pamela Garzone, Ph.D., Co-Chair of the Competition Selection & Judging Committees; Chief Development Officer of Anixa Biosciences 

Women’s Venture Competition: Dimitra Georganopoulou, Ph.D., Co-Chair of the Competition Investment Committee; General Partner of Qral Ventures

  • Johanna Webb, President of RiverWalk Therapeutics
  • Revital Mandil-Levin, Ph.D., CEO & Co-Founder of Nanocarry Therapeutics
  • Rosa Hwang, M.D., Co-Founder of Stellanova Therapeutics

BRACE Award Venture Competition: Beverly Lu, Ph.D., Co-Chair of the Competition Investment Committee; Investment Manager, Health of Emerson Collective

  • Li Chai, M.D., Co-Founder of Believer Pharmaceuticals
  • Rajiv Datar, Ph.D., Co-Founder & CEO of Propelle Therapeutics

Closing Remarks: Rose Wang, MBA, Executive Advisor of AIM-HI Accelerator Fund

2:00-2:15 pm: Coffee Break

Part III
AIM-HI Select Portfolio Companies Showcase
2:15-4:00 pm

Welcome and Opening Remarks: 

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR


  • Lora Green, Ph.D., J.D., Partner, Patents & Innovations, Wilson Sonsini Goodrich & Rosati: 
  • Critical Intellectual Property Protection Strategies & Common Pitfalls for Early-stage Companies


Panel Discussion: Opportunities & Challenges Facing Leadership of Early-stage Oncology Companies

Moderator: Raju Kucherlapati, Ph.D., Harvard Medical School

Panel Members:

  • Paul Finn, Ph.D., CSO of Oxford Drug Design Limited
  • Pritesh Gandhi, PharmD, CEO of TellBio
  • Vlad Hogenhuis, M.D., MBA, CEO of Chimera Bioengineering
  • John Luk, DMedSc, EMBA, CEO of Arbele Bio
  • Ken Malone, Ph.D., CEO of Rasio Therapeutics
  • María Varela, CEO of Ardan Pharma


Closing Remarks: 

Charlie Weatherspoon, Chair of the Board of the Director, AIM-HI Accelerator Fund

4:00-6:00 pm: Intermission

Part IV
2022 Szent-Györgyi Prize Dinner & Award Ceremony


Black Tie Optional

6:00 – 7:00 pm

Cocktail Reception

7:00 – 8:30 pm

Dinner Award Ceremony

Moment of Silence

Opening and Welcome Remarks: Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize

Introduction of the 2022 Szent-Györgyi Prize Winner:

Doug Lowy, M.D., 2018 Szent-Györgyi Prize Winner; Principal Deputy Director of the U.S. National Cancer Institute 

Award Trophy Presentation

Dr. Sujuan Ba, Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize

2022 Szent-Györgyi Prize Winner Award Speech

Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School; Director, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital

Introduction of Lance Kawaguchi, Board Member of NFCR & Chair of AFCR; CEO of Cure Brain Cancer Foundation: Sujuan Ba, Ph.D.

Introduction of Cancer Research Advocates: Lance Kawaguchi

Chelsea Hu, BASIS Independent, McLean

Greyson and Katie Banovich: Phoenix, AZ

Acknowledgments & Closing Remarks: Lance Kawaguchi


Sponsorship Opportunities

Inquiries regarding sponsorship of our Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship event can be made by e-mail at or by phone at 1-800-321-CURE (2873).

Raju Kucherlapati

“The Women’s Leadership Forum was spectacular and the chemistry between all of the people on the podium and the energy was wonderful. It was inspirational to all and especially young women who were there and might have been watching.”

-Dr. Raju Kucherlapati, Paul C. Cabot Professor of Genetics, Harvard Medical School and 2021 Precision Medicine in Cancer Panel Moderator

“Absolutely wonderful, inspirational meeting…thanks so much to everyone involved and to NFCR for making it possible for us to get together. I am grateful to be included!”

-Monica Bertagnolli, M.D., Professor, Surgery, Harvard Medical School, Former President of American Society of Clinical Oncology (ASCO), and 2021 Women’s Leadership Panel Participant


Monica Bertagnolli

Click here to see details about the sessions of our 2021 Global Summit.

All sessions from our 2021 Gobal Summit are now available on-demand on our Oncology Metaverse. 2022 Virtual participants will also be able to join the meeting from here.